Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Squamous Cell
×
Cetuximab
×
Clear all
Filters
3
NCT06064877
2025-04-13
FIERCE-HN
AVEO Pharmaceuticals, Inc.
Phase 3
Recruiting
410 enrolled
NCT02252042
2023-07-17
MK-3475-040
Merck Sharp & Dohme LLC
Phase 3
Completed
495 enrolled
32 charts